Stericycle Company Profile (NASDAQ:SRCL)

Stericycle trades on the NASDAQ under the ticker symbol "SRCL."

Stericycle, Inc. (NASDAQ:SRCL) announced its quarterly earnings data on Thursday, August, 3rd. The company reported $1.15 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.13 by $0.02. The firm earned $917.70 million during the quarter, compared to analysts' expectations of $902.81 million. Stericycle had a positive return on equity of 14.35% and a negative net margin of 0.07%. The company's quarterly revenue was up 2.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.18 EPS. View Stericycle's Earnings History.

Stericycle is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for Stericycle.

14 equities research analysts have issued 12-month target prices for Stericycle's shares. Their forecasts range from $10.00 to $108.00. On average, they anticipate Stericycle's stock price to reach $80.83 in the next twelve months. View Analyst Ratings for Stericycle.

Here are some recent quotes from research analysts about Stericycle stock:

• 1. According to Zacks Investment Research, "Stericycle reported solid second-quarter 2017 results with a healthy improvement in revenues on a year-over-year basis. The company has a competitive edge with the largest collection and transportation network in the industry, which reduces operating costs and allows it to compete effectively on both service and price perspectives. International growth rates are expected to accelerate due to increasing customer adoption and expansion into new lines of business. In addition, the acquisition pool of the company remains robust in multiple geographies and lines of business. However, low barriers to entry in the industry and stiff competition from local as well as global players significantly reduce its price control. High operating costs continue to be a headwind for Stericycle. In addition, a challenging macroeconomic environment and volatility in foreign exchange are affecting margins. Stericycle also underperformed the industry year to date." (8/7/2017)
• 2. Jefferies Group LLC analysts commented, "Even better than we were expecting and contrary to what was foreshadowed in the Jan 26 8-K, SRCL exceeded our 4Q EPS estimate by $0.05 (or 5%). The operational assumptions embedded in '17 guidance were also reaffirmed, though the mid-point of the range is $0.03 (or 1%) lower on a stronger FX headwind. Notably, the pricing resets are tracking as expected and the early pilot programs aimed at mitigating drag from future renewals are showing encouraging results." (2/16/2017)

Some companies that are related to Stericycle include Advanced Disposal Services (ADSW), Covanta Holding Corporation (CVA), US Ecology (ECOL), Renewi PLC (RWI), Casella Waste Systems (CWST), Biffa PLC (BIFF), Heritage-Crystal Clean (HCCI), Sharps Compliance Corp (SMED), Augean plc (AUG), Perma-Fix Environmental Services (PESI), Vertex Energy (VTNR), Marathon Patent Group (MARA) and Renewi PLC (SKS).

Stericycle's management team includes the folowing people:

• Mark C. Miller, Chairman of the Board
• Charles A. Alutto, President, Chief Executive Officer, Director
• Daniel V. Ginnetti, Chief Financial Officer, Executive Vice President
• Brent Arnold, Chief Operating Officer, Executive Vice President
• John P. Schetz, Executive Vice President, General Counsel
• Ruth-Ellen Abdulmassih, Executive Vice President and President, Communication & Related Services
• Michael J. Collins, Executive Vice President, President - Recall and Returns Management Services
• Brenda Frank, Executive Vice President, Chief People Officer
• Richard J. Hoffman, Senior Vice President, Chief Accounting Officer
• Jack W. Schuler, Lead Independent Director

Stericycle's stock is owned by many different of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.77%), BlackRock Inc. (6.35%), State Street Corp (4.01%), Baillie Gifford & Co. (3.10%), Fairpointe Capital LLC (2.69%) and Wells Fargo & Company MN (2.08%). Company insiders that own Stericycle stock include Daniel Ginnetti, John P Schetz, Mark C Miller, Mike S Zafirovski, Robert S Murley and Rodney F Dammeyer. View Institutional Ownership Trends for Stericycle.

Stericycle's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Ameriprise Financial Inc., TIAA CREF Investment Management LLC, Riverbridge Partners LLC, Neuberger Berman Group LLC, Carve CapitalAB, The Manufacturers Life Insurance Company and Mitsubishi UFJ Trust & Banking Corp. Company insiders that have sold Stericycle stock in the last year include John P Schetz and Mark C Miller. View Insider Buying and Selling for Stericycle.

Stericycle's stock was acquired by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, Thompson Siegel & Walmsley LLC, Strs Ohio, BlackRock Inc., Vanguard Group Inc., JPMorgan Chase & Co., Gotham Asset Management LLC and Dimensional Fund Advisors LP. Company insiders that have bought Stericycle stock in the last two years include Mike S Zafirovski and Robert S Murley. View Insider Buying and Selling for Stericycle.

Shares of Stericycle can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Stericycle stock can currently be purchased for approximately $71.90.